2019 Congress Meeting

July 19-21, 2019

La Cantera Resort & Spa
San Antonio, TX


Important advances in prevention and treatment of cardiovascular disease continue to emerge, and these advances must be consistently incorporated into clinical practice to provide the best care for patients. This congress is designed to educate clinicians on state-of-the-art care for preventing and managing cardiovascular disease. Expert faculty will cover a wide range of topics on the diagnosis, treatment, and prevention of cardiovascular disease and its risk factors. With a strong emphasis on clinical utility, attendees will be equipped with the latest evidence and practical information to improve patient outcomes. Our Congress is highly interactive with clear eyed discussion and debate. We welcome all clinicians with an interest in cutting edge preventive cardiology to attend.

Download PDF

For the most up to date schedule of events and faculty, please download the agenda from the agenda page.

There is Still Time to Register for the ASPC Congress


Cancellation Policy: 
A written notice of cancellation must be received by June 14,2019 in order to receive a refund. Cancellations received prior to this date will be honored minus a $75 administration fee. Refunds will not be honored after June 14, 2019. Telephone cancellations cannot be accepted. Cancellation refunds will be processed within 30 days after the conclusion of the Conference.

By registering for the 2019 ASPC Congress, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.

By registering for this Conference, I also give ASPC the right to publish all photos, videos, etc. taken at this Conference.


La Cantera Resort & Spa
16641 La Cantera Parkway
San Antonio, TX 78256

Room Rate: $279 plus tax; $16 daily resort fee

For Reservation Call 210-558-6500 and reference the ASPC 2019 Congress or block code ASPO719A or click here to make your reservation online.

Situated atop one the highest points in all of San Antonio, La Cantera resort has it all! This 4-star resort has fabulous dining, there are over 8 restaurants onsite, an award-winning spa and 4 amazing swimming pools, including a kids pool and splash area for toddler, and even a shopping center onsite. Enjoy the serene landscape and get you your steps in on the jogging trail. Planning on bringing the family, There are many activities for kids to participate in onsite including a kids pool and splash pad, a kids club camp, and an arcade. Looking to adventure out, jump on the complimentary shuttle to San Antonio Sea World or Six Flags Fiesta Texas located right outside the gates of La Cantera.

View the complete list of Activities for the resort

More information on Things to do in San Antonio

Congress Faculty



Amit Khera, MD, MSc, FASPC
Congress Co-Chair
President, ASPC
Professor of Medicine
Director, Preventive Cardiology
Dallas Heart Ball Chair in Hypertension
and Heart Disease
UT Southwestern Medical Center
Dallas, TX


Peter Toth, MD, PhD, FASPC
Congress Co-Chair
President-Elect, ASPC

Director, Preventative Cardiology
CGH Medical Center
Sterling, IL
Professor, Clinical Family and Community Medicine
University of Illinois College of Medicine
Peoria, IL
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, MI
Adjunct Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD



Alison Bailey, MD
Chief, Academic Cardiology
Program Director, Cardiovascular Diseases Fellowship
Division of Cardiovascular Medicine
University of Tennessee College of Medicine
Director, Preventive Cardiology & Cardiac Rehab
Erlanger Heart and Lung Institute
Chattanooga, TN


Robert Chilton, DO
Associate Professor, Department of Medicine,
Division of Cardiology
The University of Texas Health Science Center at
San Antonio
Director of the Cardiac Catheterization Laboratory
at the Audie Murphy VA and UTHSCSA
San Antonio, TX


Ana Barac, MD, PhD
Associate Professor of Medicine and Oncology
Georgetown University
Director of the Cardio-Oncology Program
MedStar Heart and Vascular Institute
Washington, DC


Ralph DeFronzo, MD
Professor of Medicine
Chief of the Diabetes Division
University of Texas Health Science Center
Deputy Director
Texas Diabetes Institute
San Antonio, TX


Deepak Bhatt, MD, MPH
Executive Director of Interventional
Cardiovascular Programs
Senior Physician
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine
Harvard Medical School
Boston, MA


Barry Franklin, PhD
Director of Preventive Cardiology and Cardiac Rehabilitation
William Beaumont Hospital
Royal Oak, MI
Professor of Physiology
Wayne State University School of Medicine
Detroit, MI
Professor of Internal Medicine and Biomedical Engineering
Oakland University William Beaumont School of Medicine
Rochester, MI.


Ron Blankstein, MD
Co-Director, Cardiovascular Imaging
Training Program
Associate Physician, Preventive Cardiology
Director, Cardiac Computed Tomography
Brigham and Women’s Hospital
Associate Professor in Medicine and Radiology
Harvard Medical School
Boston, MA


Valentin Fuster, MD, PhD, FASPC
Physician-in-Chief, Mount Sinai Hospital
Director, Mount Sinai Heart
Mount Sinai Hospital
New York, NY


Roger Blumenthal, MD, FASPC
The Kenneth Jay Pollin Professor of Cardiology
The John Hopkins Ciccarone Center for the
Prevention of Cardiovascular Disease
Baltimore, MD


Martha Gulati, MD, MS, FASPC
Treasurer, ASPC
Division Chief of Cardiology, Physician
Executive Director for the Banner University
Medicine Cardiovascular Institute
University of Arizona College of Medicine
Phoenix, AZ


Yehuda Handelsman, MD, FASPC
Medical Director and Principal Investigator
Metabolic Institute of America
Tarzana, CA


Mark Sussman, PhD
Distinguished Professor of Biology SDSU Heart Institute
San Diego State University
San Diego, CA


Pamela Morris, MD, FASPC
Professor of Medicine and Cardiology
Medical Director / Co-Director of Women’s Heart
Care Seinsheimer Cardiovascular Health Program
The Medical University of South Carolina
Charleston, SC


W.H. Wilson Tang, MD
Professor of Medicine
Cleveland Clinic Lerner College of Medicine Director of
Clinic’s Center for Clinical Genomics; Research Director
Clinical Research Unit Services
Cleveland Clinic
Cleveland, OH


Kapil Parakh, MD, MPH, PhD
Medical Lead
Google Fit
Chair, Innovative Advisory Group
American College of Cardiology
Department of Veteran Affairs
Adjunct Assistant Professor of Medicine Yale
University of Medicine
Washington, DC


Pam Taub, MD
Associate Professor of Medicine Division of
Cardiovascular Medicine, Department of Medicine
University of California (UC)
San Diego Director
Step Family Foundation Cardiovascular
Rehabilitation and Wellness Center
San Diego, CA


Michael Shapiro, DO, FASPC
Secretary, ASPC
Director of Cardiac MRI and CT Program
Associate Professor of Medicine and Radiology
Faculty, Knight Cardiovascular Institute
Oregon Health & Science University
Portland, OR


Howard Weintraub, MD, FASPC
Clinical Professor of Medicine
New York University School of Medicine Clinical
Director, NYU Center for the Prevention of
Cardiovascular Disease
Associate Director, NYU Preventive
Cardiology Fellowship
New York, NY


Laurence Sperling, MD, FASPC
Katz Professor in Preventive Cardiology
Director of the Emory Heart Disease Prevention
Center Professor of Global Health
Hubert Department of Global Health
Rollins School of Public Health at Emory University
Atlanta, GA


Abstract Submission 

The 2019 ASPC Abstract Committee invites the submission of abstracts to be
presented at the 2019 Congress on Cardiovascular Disease Prevention July 17-19,
2019, at La Cantera Resort and Spa in San Antonio, TX. Submitted abstracts will be
considered for the poster hall and the top three Young Investigator abstracts with be
picked for an oral presentation during the abstract session at the meeting. 

All abstracts must be submitted online via the ASPC abstract submission website using
the online submission form. Please be sure to read all instructions, information, and
policies closely. 

Important Dates 

Abstract Submission Deadline
Friday, April 5, 2019
5:00 p.m. EST

Abstract Acceptance Notification
Friday, May 10, 2019

Presenting Author Registration Deadline for CVD Prevention Conference
Friday, June 7, 2019

ASPC Young Investigator Awards 
Young Investigators (in training students, residents, and fellows or members in practice
for <5 years) will have the chance to compete for the ASPC's Young Investigator Award.
Cash prizes of $750, $500, and $250 will be presented to the top three Young Investigator Winners. In addition, the top three Young Investigator abstracts with be selected for an oral presentation. 

Awards Disclaimer 
If you are the recipient of one of our Young Investigator Awards, you are required to
register and attend the 2019 Congress on Cardiovascular Disease Prevention, as well
as attend all abstract-related responsibilities. These responsibilities include hanging
your poster in the Poster Hall, standing by your poster in the poster hall during the
designated times, as well as attend the oral presentation session. If you fail to attend these events, your prize and travel money could be revoked and you could be blacklisted from future abstract awards.  

Presentation Methods 
All accepted abstracts will be displayed in the Poster Hall. 

The ASPC Abstract Committee will select three Young Investigator abstracts to be
presented during the oral abstract session on Saturday, July 18, 2019. Authors will have 20-minutes to present their research (15 minutes to present and 5 minutes for questions and answers). 

Abstract Submission Instructions 

Please read through the submission instructions below before preparing your abstract: 

1. Read the General Information and Policies for the submission of an abstract. 
2. Write your abstract, following the Abstract Guidelines. 
3. Select a Topic that best relates to your abstract. 
4. Review the Acceptance and Presentation Process for abstracts. 
5. Submit your abstract through the Online Abstract Submission Form button. 
6. Register to attend the 2019 Congress on Cardiovascular Disease Prevention (ASPC staff will contact you with a meeting registration form to register for the meeting if your abstract has been approved). 

General Information and Policies 

  • Please note that if you do not mark your abstract as complete and make a FINAL submission, it will NOT be considered. Take note of any deadlines under the appropriate call for abstracts and be sure to complete the process before that date.
  • Do not CREATE your abstract in the submission system, but rather create your
    abstract in a separate Word document and COPY and PASTE it into the abstract
    submission system. This way, you will not have lost your abstract in the event of
    disconnection from the Internet, etc. Be sure to check for errors when pasting.
    Certain special characters may be changed by the browser.
  • The lead author must register for the 2019 Congress on Cardiovascular Disease
    Prevention to ensure his or her abstract(s) are included in onsite materials.
    Deadline for author registration is Friday, June 7, 2019. Lead authors MUST BE
    registrants at the ASPC Congress on Cardiovascular Disease Prevention.
    Authors who are not members of the ASPC must pay the non-member
    registration fee or can apply for membership here. Young Investigator lead
    authors with accepted abstracts will receive complimentary registration to the
  • To submit an abstract, all of the authors listed on the abstract must approve the
    final version. In addition, each author listed on the abstract should have made a
    substantial contribution to it, such as 1) contributing to the conception and design
    of the study and the acquisition of data; 2) analysis and interpretation of the data;
    and/or 3) drafting the poster and/or revising it critically for important intellectual content. Full disclosures must be provided for each author. These requirements are taken seriously by ASPC and any failure to fully comply with these requirements may result in an abstract being withdrawn from the ASPC abstracts program.
  • It is the responsibility of the lead author to ensure that his or her abstract is
    submitted correctly. 
  • Abstracts will be reviewed by the appointed ASPC Abstracts Review Committee
  • Faxed, emailed or mailed hard-copy abstracts or abstracts sent on a CD/disc WILL NOT be accepted. If you are unable to submit via the website, please contact the ASPC Annual Meeting Staff:

    Contact: Maggie Kincaid 
    Phone: 904-233-0282 

The ASPC will not be responsible for abstract submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. 

Abstract Guidelines 

Content Guidelines 

Abstracts for poster entries submitted for competition can only be accepted
electronically and must adhere to the following guidelines: 

  • Abstracts are limited to 350 words. (Word count excludes the abstract title,
    author names, and affiliations.) 
  • Abstracts must be divided into sections: Title, Background/Synopsis,
    Objectives/Purpose, Design/Methods, Results, and Conclusion that states the
    importance and potential implications of the observations. 
  • Abstracts must be proofread carefully to avoid errors before submission. 
  • Abstracts must contain generic drug names only. 
  • Abstracts must be submitted in clear English with accurate grammar and spelling
    of a quality suitable for publication.
  • Lead and secondary authors must disclose all financial relationships. 
  • Any funding support for the research must be disclosed. 
  • Encore research is eligible for submission but the original date and location of
    presentation of the research must be disclosed in the application.


The purpose of the abstract is to define the precise subject of the presentation to an
audience. Below you will find a checklist for abstract preparation. All abstracts are considered equally for selection, and the quality of the abstract is the single most important factor in the Committee&#39;s decision. 

You will be asked for the following:

  • Title 
  • Background/Synopsis - A concise description of your subject matter and prior
    work in this area.
  • Objective/Purpose - The question your material answers or the hypothesis that it
  • Methods - The experimental design or technique employed. 
  • Results - Outcomes &amp; measurements, with statistical significance, if appropriate.
  • Conclusion - Conclusions, clinical pertinence, and value or for Workshops and
    Presentations, the prevailing point of view.
  • Proofread - Make sure to proofread your abstract. Misspellings and typographical
    errors reflect badly on your scientific work. Prepare to substitute plain text for
    special characters as these characters may not be rendered reliably (i.e., plus or
    minus for ±, alpha for a etc.)
  • Authors - For each author you must provide first and last name, city and state as
    well as preliminary financial disclosure information. If you would like to be
    considered for oral presentation, the Primary Author should also upload a brief
    paragraph describing their qualifications in the chosen subject area and/or a CV. 
  • Supplemental Materials - Supplementary materials (figures, tables, illustrations)
    will not be published along with abstracts on the CLC website. If you do have
    supporting materials, we will include a link to them in the published abstract, but
    they will be housed on the ASPC website for view. 

Abstract Submission Topics 

To ensure your abstract receives proper consideration, the abstract must relate to an
appropriate topic in the field of Cardiology and cardiovascular disease prevention.
Abstract authors will be required to indicate which topic BEST matches the content of
their abstract. Topics for the 2019 ASPC Congress on Cardiovascular Disease Prevention are: 

  • ASCVD/CVD Risk Factors
  • ASCVD/CVD Risk Assessment 
  • ASCVD /CVD Risk Reduction 
  • CVD Prevention – Primary and Secondary 
  • Preventive Cardiology Best Practices – clinic operations, team approaches, outcomes research
  • Metabolic Syndrome 
  • Diabetes 
  • Kidney Disease
  • Obesity 
  • Novel Biomarkers 
  • Pharmacologic Therapy
  • Nutrition/Exercise 
  • ASCD/CVD in Women 
  • ASCVD/CVD in Special Populations 
  • Heart Failure 
  • Ischemic Stroke 
  • Peripheral Artery Disease 
  • Alterative and Complimentary Approaches 
  • Rehabilitation 
  • Other 

If you do not see an appropriate topic listed above that best relates to your abstract,
please contact the ASPC office at or call 904-233-0282. 

Acceptance and Presentation Process 

Abstract grading is blinded and abstracts are pre-screened and selected by ASPC
judges on the basis of quality and merit. You will be notified by Friday, May 10, 2019 if your poster is accepted. All lead poster authors are required to register for the 2019 Congress on Cardiovascular Disease Prevention July 19-21, 2019, at La Cantera Resort to field questions from ASPC meeting attendees. 

*Expenses related to airfare, lodging, and social events/guest fees are the responsibility
of the presenter. Special programs may be available for trainees, fellows, and young
investigators — see Young Investigator Award. 

Poster guidelines will be provided to lead authors by May 17, 2019.

Abstract Submission Form


It is our pleasure to invite you to Exhibit at our 2019 Congress on CVD Prevention, held at the La Cantera Resort and Spa in San Antonio, TX, the 2019 Annual Meeting is your opportunity to interact and market your product, device or service to the Cardiologists, Endocrinologists, Primary Care Physicians, PhD researchers, . and clinical team affiliates, from an array of disciplines including nurses, nurse practitioners, physician assistants, pharmacists, and dietitians, in a uniquely intimate educational setting. We are proud to showcase not only an agenda led by distinguished faculty who are leaders in the preventive space, but a lively exhibit hall to act as a home-base for our attendees. On behalf of our board of directors and the members we serve, we look forward to seeing you in 2019.

View the Exhibitor Prospectus 

For additional Sponsorship opportunities or Product Theater opportunities contact Maggie Kincaid.

Maggie Kincaid
Phone: (904) 233-0282

Host A Symposium

The American Society for Preventive Cardiology (ASPC) has established that independently developed CME/CE certified satellite symposia held in conjunction with the scientific meetings of the ASPC are valuable opportunities to provide continuing education for our members and meeting participants. In this regard, we are pleased to offer satellite symposia slots in conjunction with our 2019 Congress on Cardiovascular Disease Prevention.

Satellite symposia can be non-CME or CME sessions that address educational needs and performance gaps that complement the ASPC Congress scientific program agenda. The following guidelines provide important information regarding holding a Satellite Symposium at the 2019 Congress. Please contact the ASPC if you have any questions.

2018 Satellite Symposia Guidelines


Stacy Manthos
Executive Director


Maggie Kincaid
Project Manager

Application Deadline:
May 15, 2019

Onsite Events

Satellite Symposia

Friday, July 19

Non-CME Dinner Symposium

Health Economics 101: What Every Clinician Needs to Know
7:00-8:30 PM
Ballroom ABC

A health economist and preventive cardiologist will share essential information to enable clinicians to understand, critique and effectively utilize the Health Economics data that has become pervasive in our literature.

This education Activity is Sponsored educational grants from Amarin Pharma, Inc., Amgen, Inc and Sanofi Regeneron.

This event is not part of the American Society for Preventive Cardiology’s Annual Meeting as planned by the ASPC Education Committee and is not being certified for CME/CE credit.


Saturday, July 20

CME Breakfast Symposium

Redefining the Role of Cardiologist in the Management of Type 2
Diabetes: Best Practices for Cardiovascular Risk Deduction
6:30-7:45 AM
Ballroom ABC

Diabetes was once thought of as a disease of elevated blood glucose. The opportunity for cardiovascular disease (CVD) prevention in patients with Type 2 Diabetes Mellitus (T2DM) has recently expanded. Despite major therapeutic advances leading to improved outcomes over the past 2 decades, CVD remains the leading cause of morbidity and mortality in patients with TD2M. Certain sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1
receptor agonists (GLP-1 RAs) have shown significant reductions in the risk of major adverse cardiovascular events (MACE). The arrival of these new agents proven to reduce adverse CV outcomes in patients with T2DM has triggered a major paradigm shift beyond glucose control, to a broader strategy of comprehensive CV risk reduction.

Lowering the risk of CV-related death in T2DM patients can no longer be ignored. This curriculum is meant to serve as a call to action for cardiologists to reevaluate and reengage in the management of T2DM patients with CV risk.



Non-CME Dinner Symposium

6:30-8:15 PM
San Antonio Ballroom ABC
(Dinner will be provided)

“EAT Right. Exercise. And Get Your Flu Shot?
The Case for the Cardiologist’s Engagement in Influenza Prevention

Mohammad Madjid, MD, MS, FACC
Assistant Professor of Medicine McGovern Medical School
University of Texas Health Science
Center at Houston

Pam R. Taub, MD, FACC
Associate Professor of Medicine
UC San Diego Health System Division of
Cardiovascular Medicine
Director of Step Family Foundation
Cardiovascular Rehabilitation and Wellness Center

This Activity is sponsored by Sanofi Pasteur.

This event is not part of the American Society for Preventive Cardiology’s Annual Meeting as planned by the ASPC Education Committee and is not being certified for CME/CE credit.

Product Theaters

Saturday, July 20

12:10-12:55 PM
San Antonio Ballroom G
Lunch will be provided

Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study

Despite the benefits of LDL-C lowering, many patients on statin therapy with elevated triglycerides remain at risk for cardiovascular (CV) disease. In this presentation, Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study, the results from the CV outcomes trial, REDUCE-IT TM , will be reviewed. REDUCE-IT compared the number of major adverse CV events in 8179 patients with statin-controlled LDL-C, elevated triglycerides, and other CV risk factors including established CVD and diabetes.

Presenter: Pam Taub, MD, FACC
Associate Professor of Medicine
UC San Diego Medical Center
La Jolla, CA

Financial support for this program is provided by Amarin Pharma, Inc.


Saturday, July 20

12:10-12:55 PM
San Antonio Ballroom I
Lunch will be provided

Understanding the Risk and Current Treatment Options in Patients with Coronary Artery Disease (CAD) and Type 2 Diabetes (T2D) 

Presenter: John Venditto

This Activity is sponsored by AstraZeneca.


Sunday, July 21

6:45-7:50 AM
San Antonio Ballroom A
Breakfast will be provided

Lower Together: LDL-C, Risk, Hassle, Cost

Presenter: Seth J. Baum, MD, FASPC
Excel Medical Clinical Trials, LLC
Founder, Chief Medical Officer
Clinical Affiliate Professor of Biomedical Science
Department of Integrated Medical Sciences, 
Florida Atlantic University
Charles E. Schmidt College of Medicine
Medical Director, Women’s Preventive Cardiology
Christine E. Lynn Women’s Health &amp; Wellness Institute
Boca Raton Regional Hospital

This Activity is sponsored by Amgen Inc.